Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Bruker, InterWest Partners

Premium

Bruker said this week it has appointed Joshua Young vice president of investor relations. Young will take over from Stacey Desrochers, who will focus on management of the company's treasury operations.

Previously Young was global head of investor relations at Merck KGaA. Before that he was head of investor relations at Millipore.


Venture capital firm InterWest Partners announced this week that Doug Fisher has been promoted to partner.

Fisher joined InterWest as a principal in 2009 and since then has been involved in InterWest investments in a variety of biotech firms including proteomic diagnostic companies Sera Prognostics and Integrated Diagnostics.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.